12 May 2026

FemTech: Empowering female health

Tuesday, 12 May 2026 | 18:00 – 21:30 BST

DLA Piper
160 Aldersgate Street
London
EC1A 4HT

FemTech is evolving fast. Founders, investors and corporates are navigating new questions on regulation, data, IP and investment, as the sector enters its next phase of growth.

Join us on Tuesday 12 May 2026 for an evening that brings together leaders and decision makers across life sciences, technology and consumer sectors for practical insights on innovation, regulatory pathways, data protection and effective industry collaboration. Topics we will touch on during the event include genomics, personalised medicine, data protection and cybersecurity, and the growing role of AI and machine learning in women’s health.

We will welcome keynote speakers, Professor Dame Sue Hill, Chief Scientific Officer and Dr Sue Mann, Clinical Director, Women’s Health for NHS England, who will share current priorities shaping women’s health innovation in the UK. The evening will also include overviews from DLA Piper specialists, followed by a guest speakers panel session on market trends and the legal and investment landscape.

We will conclude with a networking drinks reception with peers across the UK FemTech ecosystem.

Access the hub here

Keynote speakers

Professor Dame Sue Hill

Chief Scientific Officer for NHS England

Professor Dame Sue Hill is one of the UK’s most respected leaders in science and healthcare. As Chief Scientific Officer for NHS England, she has shaped national policy, championed innovation, and led major programmes in genomics, personalised medicine, and scientific transformation across the NHS. A respiratory scientist by background and a senior academic, she played a pivotal role in delivering the 100,000 Genomes Project and establishing the world leading NHS Genomic Medicine Service. She was appointed Dame Commander of the Order of the British Empire for her contributions to genomic medicine and the NHS.

Dr Sue Mann

Clinical Director, Women's Health, NHS England

Dr Sue Mann has worked and presented widely within national, regional, and local contexts holding roles across the clinical, policy, public health and academic sectors. This has enabled her to take a broad approach to tackling the issues of the day in women's health. She holds both a national role but also continues to provide direct clinical care and local leadership for women's health in North East London where she has pioneered group consultations which has accelerated access to care for many.

Panellists

Dr Léa Wenger
Founder and CEO, Cyclana Bio

Mridula Pore
Co-founder and CEO, Peppy

Vivien de Tusch-Lec
Partner and Healthcare venture capitalist, RYSE Asset Management

Melanie Christopher
Executive Vice President and Chief Sales Officer, Capgemini

Karina Vazirova
Co-founder and CEO, FemTech Lab